‘Collateral damage’: Mass General Brigham Health Plan removes Dana-Farber from its Medicare Advantage network

Mass General Brigham Health Plan has removed Dana-Farber Cancer Institute from its Medicare Advantage network. This decision follows a previous split between Mass General Brigham and Dana-Farber, which has led to significant implications for patients seeking cancer care. The removal of Dana-Farber from the network is described as "collateral damage" in the ongoing disputes between the two prominent Boston healthcare institutions. The split has raised concerns among patients who rely on Dana-Farber for cancer treatment, as they may now face challenges in accessing care under their Medicare Advantage plans. The decision affects a substantial number of patients who are enrolled in Mass General Brigham's Medicare Advantage plan, as they will no longer have in-network access to one of the leading cancer treatment centers in the region. This change is part of a broader conflict between the two organizations, which has implications for the healthcare landscape in Boston. The situation highlights the tensions between major healthcare providers and the impact of such disputes on patient care. As Mass General Brigham and Dana-Farber navigate their differences, patients may need to seek alternative options for their cancer treatment, potentially leading to increased out-of-pocket costs or disruptions in their care continuity. The ramifications of this decision are still unfolding as stakeholders assess the effects on patient access and healthcare delivery in the area.